UroGen Pharma (URGN) Expected to Announce Quarterly Earnings on Monday
UroGen Pharma (NASDAQ:URGN – Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Monday, May 12th. Analysts expect UroGen Pharma to post earnings of ($0.83) per share and revenue of $22.71 million for the quarter. UroGen Pharma (NASDAQ:URGN – Get Free Report) last announced its earnings results […]
